Orchid Pharma Statistics

Total Valuation

Orchid Pharma has a market cap or net worth of INR 29.69 billion. The enterprise value is 31.02 billion.

Market Cap	29.69B
Enterprise Value	31.02B

Important Dates

The next estimated earnings date is Friday, May 22, 2026.

Earnings Date	May 22, 2026
Ex-Dividend Date	n/a

Share Statistics

Orchid Pharma has 50.72 million shares outstanding. The number of shares has decreased by -0.30% in one year.

Current Share Class	50.72M
Shares Outstanding	50.72M
Shares Change (YoY)	-0.30%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	24.42%
Float	15.30M

Valuation Ratios

The trailing PE ratio is 155.25 and the forward PE ratio is 23.74. Orchid Pharma's PEG ratio is 0.88.

PE Ratio	155.25
Forward PE	23.74
PS Ratio	3.66
PB Ratio	2.33
P/TBV Ratio	2.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	0.88

Financial Ratio History

Enterprise Valuation

EV / Earnings	162.72
EV / Sales	3.82
EV / EBITDA	69.40
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.22
Debt / EBITDA	6.52
Debt / FCF	n/a
Interest Coverage	0.50

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	0.51%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.01%
Revenue Per Employee	11.02M
Profits Per Employee	258,986
Employee Count	736
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.33M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.61% in the last 52 weeks. The beta is 0.36, so Orchid Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-27.61%
50-Day Moving Average	568.76
200-Day Moving Average	709.34
Relative Strength Index (RSI)	58.83
Average Volume (20 Days)	78,219

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orchid Pharma had revenue of INR 8.11 billion and earned 190.61 million in profits. Earnings per share was 3.77.

Revenue	8.11B
Gross Profit	2.76B
Operating Income	71.10M
Pretax Income	188.29M
Net Income	190.61M
EBITDA	428.55M
EBIT	71.10M
Earnings Per Share (EPS)	3.77

Full Income Statement

Balance Sheet

The company has 1.49 billion in cash and 2.82 billion in debt, giving a net cash position of -1.33 billion or -26.24 per share.

Cash & Cash Equivalents	1.49B
Total Debt	2.82B
Net Cash	-1.33B
Net Cash Per Share	-26.24
Equity (Book Value)	12.74B
Book Value Per Share	251.49
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	357.45M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 33.99%, with operating and profit margins of 0.88% and 2.35%.

Gross Margin	33.99%
Operating Margin	0.88%
Pretax Margin	2.32%
Profit Margin	2.35%
EBITDA Margin	5.28%
EBIT Margin	0.88%
FCF Margin	n/a

Dividends & Yields

Orchid Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.30%
Shareholder Yield	0.30%
Earnings Yield	0.64%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1